Current attitudes of parents and patients toward hematopoietic stem cell transplantation for sickle cell anemia

Pediatric Blood and Cancer - Tập 62 Số 7 - Trang 1277-1284 - 2015
Emily Riehm Meier1,2, Jacqueline Dioguardi1, Naynesh Kamani1
1Center for Cancer and Blood Disorders Children's National Medical Center Washington, DC 20010
2Department of Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, DC

Tóm tắt

BackgroundAllogeneic hematopoietic stem cell transplantation (HSCT) is the only available cure for sickle cell anemia (SCA). HSCT‐associated risks are one of many barriers to its widespread use for SCA. The study objective was to assess parent and patient perceptions of HSCT in the era of more widespread knowledge about HSCT for SCA.ProcedureWe surveyed parents of children with SCA and adolescents with SCA using the standard reference gamble paradigm. Survey responses between Africans (A) and African Americans (AA) and between parents and adolescents were compared.ResultsSeventy‐two percent (64/89) of the respondents were willing to accept ≥5% risk of mortality, while 57% said they would accept a risk of ≥10% of graft versus host disease (GVHD). Twenty‐two percent were unwilling to accept any risk of mortality or GVHD. Risk averseness did not differ between A or AA respondents. Fifty‐six percent of respondents were willing to accept infertility post‐HSCT.ConclusionsThese data suggest that the majority of parents and adolescents are willing to accept the current risks associated with matched sibling HSCT for SCA. However, there continue to be significant numbers of parents and adolescents who are unwilling to accept any risk of HSCT‐associated mortality or GVHD. Pediatr Blood Cancer 2015;62:1277–1284. © 2015 Wiley Periodicals, Inc.

Từ khóa


Tài liệu tham khảo

10.1016/j.pcl.2013.09.006

10.1056/NEJM199406093302303

10.1002/ajh.23683

10.1182/blood-2009-07-233700

10.1002/pbc.24557

10.1182/asheducation-2013.1.370

10.1182/blood-2013-01-435776

10.1182/blood-2007-03-079665

10.1038/sj.bmt.1705622

10.1002/pbc.24177

10.1016/j.bbmt.2009.10.005

10.1002/ajh.21570

10.1177/2040620713483063

10.1002/pbc.23304

10.1056/NEJM199111073251905

10.1016/0895-4356(89)90136-4

10.1038/sj.bmt.1703208

10.1371/journal.pone.0014699

10.1016/j.bbmt.2012.01.019

10.1038/sj.bmt.1705779

10.1002/pbc.24704

10.1016/j.bbmt.2012.05.013

Thông tin
Thông tin xuất bản

Pediatric Blood and Cancer

Tập 62 Số 7

1277-1284

Thông tin tác giả